Enquyst Technologies

Enquyst Technologies Inc.

2 Investors

Biotechnology

LOWELL, MA

Enquyst Technologies Inc. is a Massachusetts-based biotechnology company that specializes in revolutionizing the manufacturing processes of biological drugs, particularly by enhancing the purification of complex biologics. Founded in 2017, the company aims to address the inefficiencies present in traditional bioprocessing methods that hinder scalability and economic viability.

Products & Team

Integrated Purification Platform (IPP)

Bioprocessing technologySeed

The Integrated Purification Platform (IPP) is a modular and advanced purification system that leverages cutting-edge chemistry, physics, and fluid dynamics to enhance the downstream purification processes for biological drugs. It is designed for optimal efficiency, performance, and scalability.

Value Proposition

Enquyst's technology addresses the economic and scalability challenges of producing highly purified biologics, enabling biopharmaceutical companies to manufacture more effectively and affordably.

Pain Points

Customers face challenges with traditional purification processes that are costly, inefficient, and not suitable for the complex demands of modern biologic drug manufacturing.

Replaces multiple traditional chromatography operations with a single integrated solutionIncludes in-line process analytical technologies for real-time monitoring and controlSupports truly continuous manufacturing capabilitiesReduces downstream processing costs and operational complexity significantlyEnsures high-yield and high-purity purification for complex biologics